SCIENCE
Why InSphero?
Enabling Technology
3D Select™ Process
Microtissue Formats
Organ-on-a-chip Systems
Organoid Shipping
RNA Sequencing
Publications
Peer-reviewed Papers
White Papers
Posters
Blog
Digital Media
Summer School
Video
Webinar
Seminars
APPLICATIONS
Application Overview
Liver Toxicology
DILI Prediction
Mechanistic Assays
Metabolic Disease
Diabetes & Islet Research
Liver Disease
Oncology
Efficacy Testing
Immuno-Oncology
PRODUCTS
3D InSight™ Platforms
Liver
Liver Disease
Steatosis
NASH
Liver Toxicology
Human
Animal
Islet
Human
Rat
Platform Add-Ons
3D Tumor models
Assay-ready Models
PDX Models
Custom Tumor Model Development
How to Order
SERVICES
Services Overview
In Vitro
Toxicology
14 Day Hepatotoxicity
Custom Mechanistic and Investigative Studies
Pancreatic Endocrine Toxicity
Diabetes and NASH Drug Discovery
Diabetes Drug Testing
NASH Drug Testing
Oncology Drug Discovery
Custom Tumor Models Development
Efficacy Testing
Combinatorial Drug Testing
Tumor Relapse Assay
Antibody Penetration
Immuno-Oncology
Get Started with InSphero
ABOUT
About InSphero
Leadership
Careers
Contact Us
Our Partners
Consortium
News & Events
Newsletter
Media Releases
Events, Fairs & Conferences
SUPPORT
Help Center
Production Schedule
BLOG
SHOP
Get Started with Insphero
First Name
*
Last Name
*
Company/Institution
*
Email
*
Phone Number
Country
*
United States
Canada
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Antigua and Barbuda
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Brazil
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Colombia
Comoros
Congo, Democratic Republic of the
Congo, Republic of the
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Fiji
Finland
France
Gabon
Gambia
Georgia
Germany
Ghana
Greece
Greenland
Grenada
Guam
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
North Korea
South Korea
Kosovo
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
Norway
Northern Mariana Islands
Oman
Pakistan
Palau
Palestine
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Puerto Rico
Qatar
Romania
Russia
Rwanda
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
Spain
Sri Lanka
Sudan
Sudan, South
Suriname
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Togo
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Uzbekistan
Vanuatu
Vatican City
Venezuela
Vietnam
Virgin Islands, British
Virgin Islands, U.S.
Yemen
Zambia
Zimbabwe
Hidden
State/Prov
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Armed Forces Americas
Armed Forces Europe
Armed Forces Pacific
Hidden
State/Prov
Alberta
British Columbia
Manitoba
New Brunswick
Newfoundland & Labrador
Northwest Territories
Nova Scotia
Nunavut
Ontario
Prince Edward Island
Quebec
Saskatchewan
Yukon
State/Prov/Territory
Applications of Interest
Toxicity and safety testing
Cancer research
Type II diabetes and obesity research
Type 1 diabetes
Liver disease (e.g. NAFLD, NASH)
Cosmetics testing
Organs-on-chips/Microfluidics
Models of Interest
Human Liver Microtissues
Human Islet Microtissues
Monkey Liver Microtissues
Rat Islet Microtissues
Dog Liver Microtissues
Tumor/Stromal Co-cultures
Rat Liver Microtissues
Custom Tumor Model Development
Services of Interest
Liver Toxicology
Diabetes Discovery
NAFLD & NASH Discovery
Oncology Discovery
How did you hear about us?
Anything specific we can help with?
Would you like to signup to our newsletter
That would be great!
No thank you
CAPTCHA
Email
This field is for validation purposes and should be left unchanged.
Δ
